Showing 1 - 3 results of 3 for search 'Bo-Jyun Lin', query time: 0.01s Refine Results
  1. 1
    Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer

    Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer by Chih-Chieh Tu, Tsung-Han Hsieh, Cheng-Ying Chu, Yu-Chen Lin, Bo-Jyun Lin, Chun-Han Chen

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer

    FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder... by Yu-Chen Lin, Cheng-Ying Chu, Tsung-Han Hsieh, Bo-Jyun Lin, Jing-Ping Liou, Yun Yen, Chun-Han Chen

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells

    Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells by Tsung-Han Hsieh, Han-Pin Kuo, Mei-Chuan Chen, Yu-Chen Lin, Bo-Jyun Lin, Kai-Cheng Hsu, Chun-Han Chen

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: